New Research Uncovers Molecular "Firing Squad" Through Which Overeating Destroys Normal Metabolism And Sets Stage For Diabetes
February 5th, 2010 admin
Overeating in mice triggers a molecule once considered to be only involved in detecting and fighting viruses to also destroy normal metabolism, leading to insulin resistance and setting the stage for diabetes…
Related Posts
Overeating in mice triggers a molecule once considered to be only involved in detecting and fighting viruses to also destroy normal metabolism, leading to insulin resistance and setting the stage for diabetes…
Read More →
Mice that are missing a protein involved in the response to low oxygen stay lean and healthy, even on a high-fat diet, a new study has found. “They process fat differently,” said Randall Johnson, professor of biology at the University of California, San Diego, who directed the research, which is published in the April 15 issue of the journal...
Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB), a developer of alternative drug delivery systems, announced that the paper entitled, “Open-label study to assess the safety and pharmacodynamics of five oral insulin formulations in healthy subjects,” authored by Dr. Roy Eldor, Dr. Miriam Kidron and Dr. Ehud Arbit, was accepted and published...
Examination of a gene involved in cell signaling finds that four common variants of this gene are associated with the development of end-stage renal disease in Chinese patients with type 2 diabetes, according to a study in the August 25 issue of JAMA. Renal (kidney) failure is an important cause of death among patients with type 2 diabetes…
Read More →
AMP-activated protein kinase, or AMPK, is a master regulator protein of metabolism that is conserved from yeast to humans. When a cell is low on fuel, AMPK shuts down processes that use energy and turns on processes that produce energy…
Read More →
Fast Forward, LLC, the commercial drug development arm of the National Multiple Sclerosis Society, and the Juvenile Diabetes Research Foundation (JDRF), the leader in research leading to a cure for type 1 diabetes in the world announced a collaborative partnership with Axxam SpA — a leading company in conducting early-stage discovery research...
New research by University of Cincinnati (UC) scientists implicates a new protein in obesity development and highlights a protein pair’s “team effort” in regulating obesity and insulin resistance. Jorge Moscat, PhD, chair of UC’s cancer and cell biology department, says that proteins p62 and ERK are involved in adipogeneis,...
Cetero Research, the leading early-stage contract research organization (CRO), announced it has completed more than 500 diabetes research studies in the past three years for both Type 1 and Type 2 diabetics, including complex clamp studies and studies in Phase I, II, III and IV…
Read More →
People who have a family predisposition to Type 2 diabetes may be more likely to gain weight after overeating than those without a family diabetes link.
Read More →
A new understanding of insulin resistance and the action of diabetes drugs such as Avandia and Actos could pave the way for improved medications that are more selective and safer, say scientists from Dana-Farber Cancer Institute and The Scripps Research Institute…
Read More →
Related Tweets from Twitter
Related News from Digg
Leave a comment
| Trackback







